IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$494M
AUM Growth
+$192M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
157
New
Increased
Reduced
Closed

Top Buys

1
+$24.3M
2
+$22.7M
3
+$20.3M
4
PTCT icon
PTC Therapeutics
PTCT
+$14.6M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$8.84M

Top Sells

1
+$18.5M
2
+$18.4M
3
+$13.9M
4
COGT icon
Cogent Biosciences
COGT
+$12.1M
5
PRAX icon
Praxis Precision Medicines
PRAX
+$12M

Sector Composition

1 Healthcare 99.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
26
Agios Pharmaceuticals
AGIO
$1.67B
$5.1M 1.03%
+126,979
DCTH icon
27
Delcath Systems
DCTH
$298M
$4.64M 0.94%
431,251
+108,861
GPCR icon
28
Structure Therapeutics
GPCR
$4.45B
$4.57M 0.92%
163,237
-19,848
TVTX icon
29
Travere Therapeutics
TVTX
$2.61B
$4.56M 0.92%
+190,781
FBRX icon
30
Forte Biosciences
FBRX
$381M
$4.5M 0.91%
300,000
-176,443
TARS icon
31
Tarsus Pharmaceuticals
TARS
$3.26B
$4.38M 0.89%
73,619
-122,917
KRYS icon
32
Krystal Biotech
KRYS
$7.71B
$4.31M 0.87%
+24,421
ARGX icon
33
argenx
ARGX
$46.3B
$4.3M 0.87%
+5,942
VTYX icon
34
Ventyx Biosciences
VTYX
$1B
$4.07M 0.82%
1,309,604
+342,014
PVLA
35
Palvella Therapeutics
PVLA
$1.56B
$4.06M 0.82%
+64,746
SLNO icon
36
Soleno Therapeutics
SLNO
$2.03B
$3.78M 0.77%
+55,946
LXEO icon
37
Lexeo Therapeutics
LXEO
$516M
$3.77M 0.76%
567,601
+17,572
LABD icon
38
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$74.9M
$3.72M 0.75%
+91,959
RLMD icon
39
Relmada Therapeutics
RLMD
$342M
$3.7M 0.75%
1,843,060
+1,802,790
QURE icon
40
uniQure
QURE
$562M
$3.42M 0.69%
58,610
-61,376
VIR icon
41
Vir Biotechnology
VIR
$1.4B
$3.39M 0.69%
593,374
-474,688
MLTX icon
42
MoonLake Immunotherapeutics
MLTX
$1.27B
$3.12M 0.63%
+435,839
NAMS icon
43
NewAmsterdam Pharma
NAMS
$3.5B
$3.04M 0.61%
106,800
-100,000
UPB
44
Upstream Bio Inc
UPB
$398M
$3.03M 0.61%
+161,113
GUTS icon
45
Fractyl Health
GUTS
$77.5M
$2.86M 0.58%
+1,800,000
BBOT
46
BridgeBio Oncology
BBOT
$779M
$2.84M 0.57%
+245,231
BBIO icon
47
BridgeBio Pharma
BBIO
$12.5B
$2.7M 0.55%
+51,967
PEPG icon
48
PepGen
PEPG
$441M
$2.48M 0.5%
535,967
+385,967
STIM icon
49
Neuronetics
STIM
$87M
$2.47M 0.5%
905,716
-193,984
RLAY icon
50
Relay Therapeutics
RLAY
$1.71B
$2.44M 0.49%
467,362
-275,946
1
2
3 4 5